Chemours is trading $15.45 (+4.39%) with no verified August 11 company-specific after-hours announcement or late-breaking catalyst identified.
- It closed at $14.80 after the August 11, 2026 regular session.
- Recent coverage focused on the second-quarter earnings miss, weaker volumes, cautious outlook, and Morgan Stanleyβs August 10 price-target reduction to $18.
- The broader market was lower, so market sentiment does not clearly explain the upward move.